Skip to main content
. 2020 May 8;88:901–907. doi: 10.1016/j.bbi.2020.05.026

Table 1.

Summary of characteristics of included studies.

Author Study Population Response rate (%) Region Health care workers
Male% Assessment Cut-off Outcomes
Physicians Nurses Other Depression% (n) Anxiety% (n) Insomnia% (n)
Du et al. (2020) 134 43·2% China 35·1% 41·0% 23·9% 39·6% BDI-II
BAI
≥14
≥8
12·7%
(17)
20·1%
(28)
N.A.
Guo et al. (2020) 11,118 N.A. China 30·28% 53·07% 16·65% 25·2% SAS
SDS
≥50
≥50
31·45%
(3497)
17·45%
(1940)
N.A.
Huang et al. (2020a) 230 93·5% Fuyang 30·4% 69·6% 0·0% 18·7% SAS ≥50 N.A. 23·04%
(53)
N.A.
Huang and Zhao (2020) 2250 85·3% China N.A. N.A. N.A. N.A. CES-D
GAD-7
≥28
≥9
19·8%
(446)
35·6%
(802)
23·6%
(531)
Lai et al. (2019) 1257 68·7% Wuhan 39·2% 60·8% 0·0% 23·3% GAD-7
ISI
PHQ-9
≥5
≥8
≥5
50·4%
(634)
44·6%
(560)
34%
(427)
Liu et al. (2020) 512 85·3% China N.A. N.A. N.A. 15·4% SAS ≥50 N.A. 12·5%
(64)
N.A.
Liu et al. (2020) 4679 N.A. China 39·6% 60·4% 0·0% 17·7% SAS
SDS
≥50
≥50
34·6%
(1619)
16·0%
(749)
N.A.
Lu et al. (2020) 2299 94·88% Fujian 88·8% 11·2% 22·4% HAMA
HAMD
≥7
≥7
11·7%
(268)
24·7%
(569)
N.A.
Qi et al. (2020) 1306 93·6% China N.A. N.A. N.A. 19.6% AIS
PSQI
>6
>7
N.A. N.A. 45·5%
(594)
Tan et al. (2020) 470 94·0% Singapore 28·7% 34·3% 37·0% 31·7% DASS-21 D > 9
A > 7
8·9%
(42)
14·5%
(68)
N.A.
Zhang et al. (2020a) 1563 N.A. China 29·0% 62·9% 7·9% 17·3% GAD-7
ISI
PHQ-9
≥5
≥8
≥5
50·7%
(792)
44·7%
(699)
36·1%
(564)
Zhang et al. (2020b) 2182 N.A. China 31·2% 11·3% 57·5% 35·8% ISI
GAD-2
PHQ-2
>8
≥3
≥3
10·6%
(232)
10·4%
(228)
33·9%
(739)
Zhu et al. (2020) 5062 77·1% Wuhan 19·8% 67·5% 12·7% 15% GAD-7
PHQ-9
≥8
≥10
13·45%
(681)
24·06%
(1218)
N.A.

All studies are cross-sectional; the absolute number of patients for each category is included in the brackets.